Statizoid

Health in Low income (World Bank)

150 indicators covering health for Low income (World Bank).

IndicatorLatest Year10-yr change Rank
UHC Service Coverage sub-index on reproductive, maternal, newborn and 51 2023 down 3.8% 13th
UHC Service Coverage Index 47 2023 up 9.3% 13th
UHC Service Coverage sub-index on noncommunicable diseases 67 2023 up 21.8% 3rd
Stillbirth rate 23.29 2023 down 11.5% 1st
Rotavirus vaccines completed dose (RotaC) immunization coverage among 64.0% 2025 up 77.8% 6th
Current health expenditure (CHE) as percentage of gross domestic 6.4% 2023 up 15.6% 7th
External health expenditure (EXT) as percentage of current health 31.7% 2023 down 1.3% 1st
Domestic general government health expenditure (GGHE-D) as percentage 20.1% 2023 down 1.4% 11th
Out-of-pocket expenditure as percentage of current health expenditure 43.8% 2023 up 1.4% 1st
Domestic general government health expenditure (GGHE-D) as percentage 1.1% 2023 up 2.3% 11th
Domestic general government health expenditure (GGHE-D) as percentage 5.5% 2023 up 1.2% 11th
Domestic private health expenditure (PVT-D) as percentage of current 48.2% 2023 up 1.5% 1st
Current health expenditure (CHE) per capita in US$ 45.14 2023 up 11.7% 11th
Domestic private health expenditure (PVT-D) per capita in US$ 22.7 2023 up 7.6% 11th
Domestic general government health expenditure (GGHE-D) per capita in 8.28 2023 up 6.0% 11th
Mumps - number of reported cases 41,584 2025 up 135.2% 6th
Incidence of tuberculosis (per 100 000 population) 19 2023 down 50.0% 2nd
Congenital Rubella Syndrome - number of reported cases 256 2025 — 4th
External health expenditure (EXT) per capita in US$ 14.16 2023 up 23.0% 7th
Raised blood pressure (SBP>=140 OR DBP>=90) 30 2019 down 8.7% 3rd
Raised blood pressure (SBP>=140 OR DBP>=90) 27.59 2019 down 8.3% 4th
Hypertension: diagnosis coverage among adults aged 30-79 with 40.5% 2019 up 29.0% 10th
Hypertension among adults aged 30-79 years, prevalence 34.2 2019 down 3.4% 5th
Hypertension effective treatment coverage (controlled hypertension) 10.7% 2019 up 75.4% 11th
Hypertension: effective treatment coverage (controlled hypertension) 10.1% 2019 up 74.1% 11th
Hypertension treatment coverage among adults aged 30-79 with 23.9% 2019 up 30.6% 11th
Hypertension treatment coverage among adults aged 30-79 with 25.9% 2019 up 31.5% 11th
Hypertension: diagnosis coverage among adults aged 30-79 with 38.3% 2019 up 29.4% 11th
Hypertension among adults aged 30-79 years, prevalence, crude 31.3 2019 down 3.4% 9th
Pneumococcal conjugate second or third-dose vaccines (PCVc) 68.0% 2025 up 13.3% 8th
Treatment success rate: previously treated TB cases 79 2023 up 6.8% 5th
Prevalence of insufficient physical activity among adults aged 18+ 15.2% 2022 down 2.3% 11th
Prevalence of insufficient physical activity among adults aged 18+ 17.0% 2022 down 2.3% 11th
TB patients with known HIV status 86.0% 2024 up 41.0% 4th
Confirmed cases of RR-/MDR-TB 7,622 2024 up 216.4% 9th
Tested TB patients HIV-positive 13.0% 2024 down 55.2% 4th
New cases tested for RR-/MDR-TB 48.0% 2024 up 1,746.2% 11th
Age-standardized suicide rates 10.47 2021 down 0.1% 3rd
Premature deaths due to noncommunicable diseases (NCD) as a 61.9 2021 down 0.6% 2nd
Total NCD Deaths 1.97 million 2021 up 27.5% 11th
Probability (%) of dying between age 30 and exact age 70 from any of 23.1% 2021 down 6.9% 1st
Life expectancy at age 60 16.48 2021 up 1.4% 10th
Age-standardized NCD mortality rate 626.37 2021 down 5.9% 1st
Mortality rate attributed to unintentional poisoning 1.39 2021 down 7.3% 1st
Life expectancy at birth 63.67 2021 up 4.5% 10th
Adult mortality rate (probability of dying between 15 and 60 years) 244.84 2021 down 8.9% 2nd
Previously treated cases tested for RR-/MDR-TB 56.0% 2024 up 154.5% 11th
Healthy life expectancy (HALE) at age 60 12.47 2021 up 0.8% 9th
nMx - age-specific death rate between ages x and x+n 0.048 2021 down 23.3% 2nd
nLx - person-years lived between ages x and x+n 96,683 2021 up 1.0% 10th
lx - number of people left alive at age x 100,000 2021 unchanged 1st
nqx - probability of dying between ages x and x+n 0.0464 2021 down 22.5% 2nd
Tx - person-years lived above age x 6.37 million 2021 up 4.5% 10th
Healthy life expectancy (HALE) at birth 55.28 2021 up 4.2% 10th
ex - expectation of life at age x 63.67 2021 up 4.5% 10th
ndx - number of people dying between ages x and x+n 4,637 2021 down 22.5% 2nd
Cases started on MDR-TB treatment 7,337 2024 up 259.3% 9th
Raised fasting blood glucose (>=7.0 mmol/L) 6.6 2014 up 22.2% 12th
Raised fasting blood glucose (>= 7.0 mmol/L) 4.8 2014 up 23.1% 12th
Percentage of total deaths due to NCDs overall and percentage of 48.63 2019 down 19.7% 2nd